ArticleNPJ Regenerative medicine2021

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS.

Ashok K Shetty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.